Abivax (ABVX) PT Lowered to $136 at Wolfe Research

June 3, 2026 12:49 PM

Wolfe Research analyst Steve Fleishman lowered the price target on Abivax (NASDAQ: ABVX) to $136.00 (from $176.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found